| Product Code: ETC7601694 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Antithrombotic Drugs Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Iraq Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Iraq Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Iraq Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Iraq Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Iraq Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Iraq Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Iraq Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Iraq Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Iraq |
4.2.2 Growing awareness about the importance of antithrombotic drugs in preventing heart attacks and strokes |
4.2.3 Rise in healthcare expenditure and improving healthcare infrastructure in Iraq |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in certain regions of Iraq |
4.3.2 Lack of awareness among the general population about antithrombotic drugs and their benefits |
4.3.3 Challenges related to affordability and reimbursement issues for antithrombotic medications in Iraq |
5 Iraq Antithrombotic Drugs Market Trends |
6 Iraq Antithrombotic Drugs Market, By Types |
6.1 Iraq Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Iraq Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Iraq Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Iraq Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Iraq Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Iraq Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Iraq Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Iraq Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Iraq Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Iraq Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Iraq Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Iraq Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Iraq Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Iraq Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Iraq Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Iraq Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Iraq Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Iraq Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Iraq Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Iraq Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Iraq Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Iraq Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Iraq Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Iraq Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Iraq Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Iraq Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Iraq Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Iraq Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Iraq Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Iraq Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Iraq Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Iraq Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Iraq Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Iraq Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Iraq Antithrombotic Drugs Market Export to Major Countries |
7.2 Iraq Antithrombotic Drugs Market Imports from Major Countries |
8 Iraq Antithrombotic Drugs Market Key Performance Indicators |
8.1 Number of patients prescribed antithrombotic drugs in Iraq |
8.2 Rate of adherence to antithrombotic drug therapy among patients |
8.3 Number of healthcare professionals trained in the proper use of antithrombotic drugs |
8.4 Level of government initiatives and policies supporting the use of antithrombotic drugs |
8.5 Rate of adverse events or complications related to antithrombotic drug usage |
9 Iraq Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Iraq Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Iraq Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Iraq Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Iraq Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Iraq Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Iraq Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Iraq Antithrombotic Drugs Market - Competitive Landscape |
10.1 Iraq Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Iraq Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here